Oklahoma

Psychedelic trials in Oklahoma

12 registered trials has a study site in Oklahoma, and 4 are recruiting now.

12

Trials with a site here

4

Recruiting

8

Facilities

Open now

Recruiting in this state

Trial	Status	Phase	Substance	Sites
IN Midazolam vs IN Dexmedetomidine vs IN Ketamine During Minimal Procedures in Pediatric EDNCT05934669 · University of Oklahoma	Recruiting	Phase 4	ketamine	1
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive DisorderNCT06793397 · Cybin IRL Limited	Recruiting	Phase 3	psilocybin	68
PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence StudyNCT06713616 · Yale University	Recruiting	Phase 3	ketamine	8
The OBSERVE ProtocolNCT06725277 · Yale University	Recruiting	N/A	ketamine	8

Facilities

Where the research happens in Oklahoma

Facility	City	Trials
LifeStance Health	Moore	2
University of Oklahoma Health Sciences Center	Oklahoma City	1
SP Research PLLC	Oklahoma City	1
Paradigm Research Professionals, LLC	Oklahoma City	1
Jackson C. Montgomery VA Medical Center, Muskogee, OK	Muskogee	1
Rivus Wellness & Research Institute	Oklahoma City	1
IPS Research Company	Oklahoma City	1
Clinical Site 135	Oklahoma City	1

Stay told

When a trial opens in Oklahoma

All trials

Every trial with a Oklahoma site

Trial	Status	Phase	Substance	Sites
IN Midazolam vs IN Dexmedetomidine vs IN Ketamine During Minimal Procedures in Pediatric EDNCT05934669 · University of Oklahoma	Recruiting	Phase 4	ketamine	1
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive DisorderNCT06793397 · Cybin IRL Limited	Recruiting	Phase 3	psilocybin	68
PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence StudyNCT06713616 · Yale University	Recruiting	Phase 3	ketamine	8
The OBSERVE ProtocolNCT06725277 · Yale University	Recruiting	N/A	ketamine	8
A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant DepressionNCT04599855 · Janssen Research & Development, LLC	Completed	Phase 4	ketamine	54
VA Aripiprazole vs Esketamine for Treatment Resistant DepressionNCT05554627 · VA Office of Research and Development	Withdrawn	Phase 4	ketamine	26
Efficacy, Safety, and Tolerability of COMP360 in Participants With TRDNCT05624268 · COMPASS Pathways	Completed	Phase 3	psilocybin	40
A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant DepressionNCT02417064 · Janssen Research & Development, LLC	Completed	Phase 3	ketamine	90
A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant DepressionNCT02493868 · Janssen Research & Development, LLC	Completed	Phase 3	ketamine	155
A Long-term Safety Study of Esketamine Nasal Spray in Treatment-resistant DepressionNCT02782104 · Janssen Research & Development, LLC	Completed	Phase 3	ketamine	173
A Study to Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant DepressionNCT03434041 · Janssen Research & Development, LLC	Completed	Phase 3	ketamine	30
A Study of CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive DisorderNCT06340958 · Clexio Biosciences Ltd.	Completed	Phase 2	ketamine	23

Site locations from ClinicalTrials.gov API v2, data build 2026-08-25.

Elsewhere

Other states